Regionalisation is No Silver Bullet for NHS Diagnostic Pressures - but it Must Not Fail

Change HealthcareOpinion Article by Richard Turner, Executive Director, Change Healthcare
In the late 1990s, radiology was a very different place. Still analogue, departments relied on light boxes, and professionals performedmore specific site-based roles. At the time, I worked in the radiology department of a London hospital, and started a change programme with my hospital colleagues to shake up roles.

We taught radiographers to give IV injections, and to do basic nursing care. We started teaching nursing staff to order imaging. And we encouraged radiographers to carry out reporting and procedures likebarium enemas. The sort of approaches we instigated are now common. For example, when a patient goes for a maternity ultrasound today, a midwife might perform the scan. But 20 years ago, we were quite leading edge in the NHS, and even caught the attention of the then prime minister Tony Blair, whoasked me on a visit to ourambulatory care service,'should all hospitals do this?'.

Importantly, we were trying to spread skillsets and to break down boundariesover who's job a task might be. We were also innovating with technology like the hospital's picture archiving and communication system, or PACS, and centralised booking to achieve our aims. This was about focussing care delivery around the patient, rather than the professional or institution. It meant a seamless move for the patient throughout the organisation; that they could access services, professionals and appointments in a single attendance.

Jump forward two decades, and the diagnostic regionalisation agenda now spreading across the NHS, is not so different in ambition. This is just as much about pushing boundaries, spreading skills, and centring services around patient needs.

Care has left the hospital

A lot has progressed since my early NHS days. The digitisation of radiology, for example, has had a big impact on effective reporting, diagnoses and care. The question now being asked is whether technologies and even whether diagnostic disciplines can remain confined to an individual hospital.

In places like Ireland, PACS has already been deployed nationally, with significant positive implications for the ability to report on any patient, regardless of location.

And in England, similar sized populationsare starting to benefit from region-wide PACS that cover multiple trusts to support visionswhere imaging records can be accessed and reported on from any appropriate location, by any appropriate healthcare professional.

Care really has left the confines of the hospital. What we did in the 90s and noughties is long past - and the siloed approaches for institutional diagnostics are no longer relevant for an NHS where greater collaboration is required, and where patients expect their imaging to follow them.

Regionalisation is fundamental to ending institutional level boundaries, and the benefits are so great that the agenda must prevail.

Prioritising: patients, providers, professionals

We are about to witness a major change in access to diagnostic services. Regionalisation will break down care and resource barriers, and by intelligently prioritising workflow across providers, there is an opportunity to deliver the equitable access to professionals and expertise that patients need.

Cancer referrals have a greater chance of being addressed inrequired timeframes. For screening, if your hospital's mammography specialist isn’t available, then there is suddenly a regional number of professionals to draw on. A production level of diagnostics and referral can be maintained with a bigger pool of staff.

For emergency care like a head injury, a clinician in a busy hospital might struggle to findthe radiologist needed. In a region, multiple consultants can review the image, allowing faster diagnosis.

Andregional approaches can inform the best decision on where a patient receives care. Several years agoa patient presented to their hospital with flu-like illness. They had progressive shortness of breath, and pleuritic chest pain. The patient’s imaging was read at another hospital, before the individual was transferred to the region’s specialist centre – the best place to treat eosinophilicpneumonia. Only by working together could the three sites involved identify the illness and the most appropriate response. As diagnostic regionalisation spreads, this collaboration could become far more commonplace in the NHS.

Bigger peer review and regional best practice

An entirely new culture of sharing best practice could be on the horizon, with big implications for improving quality. Regionalisation can enhance expertise in a way that wouldn’totherwise exist.

Through peer support, and knowledge transfer, quality can be driven up regionwide. For instance, when hospital A is performing well at a particular function, can it share its approach with the lower performing hospital B?

Individuals too can benefit enormously from being part of a bigger setting. As data flows across the region, teaching resources can be built from far bigger datasets of a quality not previously seen, with implications for training a highly informed next generation of diagnostic professionals.

Larger peer groups can also allow for better working conditions - not only from the perspective of balancing worklists, but from better access to colleagues. In an ever increasingly pressured NHS environment, healthcare professionals can be slightly less stressed around making the right decision, when they can share peer review to allow validation they are making the right diagnosis for a patient.

Overcoming resistance

The NHS must be careful not to repeat the mistakes of the past around matters like engagement. Staff might ask themselves: "Am I still in control? Am I still the eminent specialist?" But the benefits for these individuals can be huge, with possibilities like home-based reporting, and the potential to play a bigger role across the regional community.

More importantly, in their DNA, professionals are singularly focussed on patient outcomes. When they can see the impact on outcomes from moving to regionalised diagnostics, they will undoubtedly support the ambition.

No silver bullet

A new regionalised landscape has tremendous potential to instil new confidence in the ways illnesses are diagnosed. But the NHS must be careful not to expect regionalisation to solely solve the rising demand and diminishing resource challenge so often cited in discussions.

Will it make a difference to the workload? Quite probably in the shorter term. But demand will continue to rise, and there will come a point where other interventions are needed - whether that is AI or new approaches to prevention, big data and population health.

Regionalisation is not the silver bullet, but for everything it does mean to improving care, it must not be allowed to fail.

Most Popular Now

Stepping Hill Hospital Announced as SPAR…

Stepping Hill Hospital, part of Stockport NHS Foundation Trust, has replaced its bedside units with state-of-the art devices running a full range of information, engagement, communications and productivity apps, to...

DMEA 2025: Digital Health Worldwide in B…

8 - 10 April 2025, Berlin, Germany. From the AI Act, to the potential of the European Health Data Space, to the power of patient data in Scandinavia - DMEA 2025...

Is AI in Medicine Playing Fair?

As artificial intelligence (AI) rapidly integrates into health care, a new study by researchers at the Icahn School of Medicine at Mount Sinai reveals that all generative AI models may...

New System for the Early Detection of Au…

A team from the Human-Tech Institute-Universitat Politècnica de València has developed a new system for the early detection of Autism Spectrum Disorder (ASD) using virtual reality and artificial intelligence. The...

Generative AI's Diagnostic Capabili…

The use of generative AI for diagnostics has attracted attention in the medical field and many research papers have been published on this topic. However, because the evaluation criteria were...

Diagnoses and Treatment Recommendations …

A new study led by Prof. Dan Zeltzer, a digital health expert from the Berglas School of Economics at Tel Aviv University, compared the quality of diagnostic and treatment recommendations...

AI Tool can Track Effectiveness of Multi…

A new artificial intelligence (AI) tool that can help interpret and assess how well treatments are working for patients with multiple sclerosis (MS) has been developed by UCL researchers. AI uses...

Surrey and Sussex Healthcare NHS Trust g…

Surrey and Sussex Healthcare NHS Trust has marked an important milestone in connecting busy radiologists across large parts of South East England, following the successful go live of Sectra's enterprise...

Dr Jason Broch Joins the Highland Market…

The Highland Marketing advisory board has welcomed a new member - Dr Jason Broch, a GP and director with a strong track record in the NHS and IT-enabled transformation. Dr Broch...

DMEA 2025 Ends with Record Attendance an…

8 - 10 April 2025, Berlin, Germany. DMEA 2025 came to a successful close with record attendance and an impressive program. 20,500 participants attended Europe's leading digital health event over the...

Multi-Resistance in Bacteria Predicted b…

An AI model trained on large amounts of genetic data can predict whether bacteria will become antibiotic-resistant. The new study shows that antibiotic resistance is more easily transmitted between genetically...

AI-Driven Smart Devices to Transform Hea…

AI-powered, internet-connected medical devices have the potential to revolutionise healthcare by enabling early disease detection, real-time patient monitoring, and personalised treatments, a new study suggests. They are already saving lives...